DR-TB STAT

Practice-based recommendations for the management of RR/MDR-TB

Statement from DR-TB STAT and TAG outlining practice-based recommendations for the optimal management of RR/MDR-TB. 

Read More →

Crisis of confidence in the WHO's ability to produce normative guidance for the treatment of RR-/MDR-TB

Advocates request an urgent in-person meeting with the WHO leadership to discuss concrete actions to address technical and guideline development process-related issues previously raised.

Read More →

Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB

Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.

Read More →

An Activist’s Guide to Bedaquiline (Sirturo)

The guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.

Read More →

Activists: Call on your countries to use bedaquiline-based regimens to treat TB

The Global Coalition of TB Activists (GCTA), Treatment Action Group (TAG) and the DR-TB Scale-Up Treatment Action Team (DR-TB STAT) developed a letter template to help activists call for bedaquiline-based, injectable-free regimens for the treatment of drug-resistant TB in their countries.

Read More →

Webinar on implementing an injectable-free regimen for drug-resistant TB - materials now available online

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB), the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) and TB Proof hosted a webinar on 16 August 2018 on implementing an injectable-free regimen for drug-resistant TB.

Read More →

Webinar: Implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and the Drug-Resistant TB Treatment Scale-up Action Team (DR-TB STAT) will host a webinar on 16 August 2018 at 10 am EDT / 4 pm South Africa / 5 pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB (DR-TB) in light of the new World Health Organization (WHO) policy brief on DR-TB regimens.

Read More →

Webinar: Implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB

Treatment Action Group (TAG), the Global TB Community Advisory Board (TB CAB) and DR-TB STAT will host a webinar on 1 August 2018 at 10 am New York / 4pm South Africa / 5pm Kenya on implementing a bedaquiline-based, injectable-free regimen for drug-resistant TB.

Read More →

New guide to shorter regimen for treating drug-resistant TB

DR-TB STAT + TAG brief: Is Shorter Better? Understanding the Shorter Regimen For Treating Drug-Resistant Tuberculosis

Read More →

New guide: Your rights and TB care

An innovative and important new TB resource – Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide.

Read More →

Page 1 of 2 · Total posts: 10

1 2 Last→